Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366742 · ClinicalTrials.gov registry record
Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women
A clinical trial of Human Papillomavirus and CIN 2, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 900
- Enrollment target
- 2
- Study locations
NCT01366742 is a study of Human Papillomavirus and CIN 2 that has completed, run by University of California, Los Angeles. The registered enrollment target is 900 participants, below the 26,007-participant average among 12 other Human Papillomavirus trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01366742, a study of Human Papillomavirus and CIN 2, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 900 participants
- Enrollment target
- 2
- Study locations
Study Summary
The natural history of human papillomavirus (HPV) is most likely influenced by both innate and adaptive mucosal immunity. More specifically, we hypothesize that Toll like receptors (TLR) play an important role in cervical innate immunity to HPV through secretions of proinflammatory, chemotactic and anti-viral cytokines. Up-regulated TLR expression will also result in activation of dendritic cells and T cells that in turn will promote a T helper (Th) l like response through secretion of several cytokines and consequently, the induction of a successful cell mediated immune (CMI) response.
Conditions Studied
Study Locations (2)
California
- SFSU Student Health Center - San Francisco
- HPV Study - San Leandro Office - San Leandro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 1987-12 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01366742
The ClinicalTrials.gov registry entry for NCT01366742 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,007-participant average among 12 other Human Papillomavirus trials with a reported enrollment target (97% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Human Papillomavirus appearing as the primary indexed condition, and to 0 interventions.
NCT01366742 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01366742 about?
NCT01366742 is a clinical study titled "Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women". The natural history of human papillomavirus (HPV) is most likely influenced by both innate and adaptive mucosal immunity. More specifically, we hypothesize that Toll like receptors (TLR) play an important role in cervical innate immunity to HPV through secretions of proinflammatory, chemotactic and ...
What is the current status of trial NCT01366742?
This trial is currently completed. The enrollment target is 900 participants. The study started on 1987-12. Estimated completion is 2016-05.
What conditions does trial NCT01366742 study?
This clinical trial studies the following conditions: Human Papillomavirus, CIN 2, CIN 3.
Who is sponsoring clinical trial NCT01366742?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01366742 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papillomavirus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Provider Recommendation and HPV Vaccination
RECRUITING · NA
-
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
RECRUITING
-
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
RECRUITING · Phase 4
-
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
RECRUITING
-
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
ACTIVE NOT RECRUITING · Phase 1
-
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.